logo

For the Inventor, By the Inventor

Kirkland, Canada

Petpiboon Prasit

This inventor holds 28 USPTO granted patents, primarily in Cyclooxygenase Inhibitors. Top assignees: Merck Frosst Canada, Inc., Merck Frosst Canada & Co., Merck + Co., Inc.. Active years: 1992-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Petpiboon Prasit. Retrieved from https://idiyas.com/inventor/petpiboon-prasit

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28

% Patents Active = 96.4

Average Co-Inventor Count = 5.5

ph-index = 14

Forward Citations = 1,528(Granted Patents)


Location History:

  • Quebec, CA (1996)
  • Pierreponds, CA (2001)
  • Kirkland, CA (1992 - 2002)

Company Filing History:

goldMedal22 out of 212 
 
Merck Frosst Canada, Inc.
 patents
silverMedal5 out of 80 
 
Merck Frosst Canada & Co.
 patents
bronzeMedal1 out of 4,770 
 
Merck + Co., Inc.
 patents

Years Active: 1992-2002

Loading Chart...
Areas of Expertise:
Cyclooxygenase
Neurodegenerative Diseases
Caspase-3
Prodrugs
Leukotriene Antagonists
Bicyclic Heterocycles
Indole Derivatives
Phenyl Heterocycles
Azaarylmethoxy
Alkanesulfonamido
Quinoline Ether
Phospholipase A.sub.2
28 patents (USPTO):Explore Patents
1. 6486194 - Use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases (2002-11-26),
2. 6329421 - Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2 (2001-12-11),
3. 6225288 - Gamma-ketoacid dipeptides as inhibitors of caspase-3 (2001-05-01),
4. 6222048 - Diaryl-2-(5H)-furanones as Cox-2 inhibitors (2001-04-24),
5. 6169188 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors (2001-01-02),
6. 6057319 - 3,4-Diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors (2000-05-02),
7. 6020343 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors (2000-02-01),
8. 5981576 - (Methylsulfonyl)phenyl-2-(5H)-furanones as COX-2 inhibitors (1999-11-09),
9. 5925631 - Alkylated styrenes as prodrugs to COX-2 inhibitors (1999-07-20),
10. 5840746 - Use of inhibitors of cyclooxygenase in the treatment of (1998-11-24),
11. 5789413 - Alkylated styrenes as prodrugs to COX-2 inhibitors (1998-08-04),
12. 5710140 - Phenyl heterocycles as COX-2 inhibitors (1998-01-20),
13. 5698584 - 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to COX-2 inhibitors (1997-12-16),
14. 5550142 - Phenyl heterocycles as cox-2 inhibitors (1996-08-27),
15. 5536752 - Phenyl heterocycles as COX-2 inhibitors (1996-07-16),

Title: Unveiling the Impactful Work of Petpiboon Prasit in Innovation

Introduction:

Petpiboon Prasit, a prolific inventor, has made significant contributions to the field of medicine and neurology with his groundbreaking patents. Hailing from Kirkland, CA, Prasit has a remarkable portfolio of 28 patents under his belt, showcasing his relentless pursuit of innovation and excellence.

Latest Patents:

One of Prasit's latest patents involves the use of inhibitors of cyclooxygenase in the treatment of neurodegenerative diseases. This innovative method aims to treat conditions such as Alzheimer's disease by administering non-steroid COX-II inhibitors to patients in need. Prasit's preference for compounds of Formula I: Diaryl bicyclic heterocycles highlights his commitment to developing effective treatments for neurodegenerative diseases.

Career Highlights:

Prasit has left an indelible mark on the industry through his tenure at Merck Frosst Canada, Inc., and Merck Frosst Canada & Co. His expertise and dedication have paved the way for groundbreaking advancements in the pharmaceutical sector, earning him recognition as a trailblazer in the field of medicine.

Collaborations:

Throughout his career, Prasit has collaborated with esteemed colleagues such as Serge Leger and Zhaoyin Wang. These fruitful partnerships have fostered a culture of innovation and knowledge-sharing, leading to the development of cutting-edge solutions in the realm of neurology and medicine.

Conclusion:

In conclusion, Petpiboon Prasit's innovative spirit and unwavering dedication to scientific advancement have established him as a revered figure in the world of invention. His pioneering work in the treatment of neurodegenerative diseases serves as a testament to his ingenuity and commitment to improving human health and well-being.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…